Health & Biotech HealthKick Podcast: NGS’s growth just accelerated with launch into 403 select Walmart stores August 30, 2022 Tim chats with Liron Fendell, CEO and managing director of Nutritional Growth Solutions (ASX:NGS) on their US expansion plans. ASX Health Stocks: HITIQ signs renewed deal with English cricket to manage concussion injuries August 29, 2022 HITIQ (ASX:HIQ) has renewed a subscription agreement with the English Cricket Broad (ECB) for another two years. ASX Health Stocks: Patrys wins fresh grant, IDT does not and Next Science is off to sell stuff in Canada August 26, 2022 Patrys gets research grant to progress lead drug Next Science gets Canada license Bad news for IDT Australia Cancer fighter… Weed Week: Legal use of medicinal cannabis in Australia on the rise, Lambert Initiative says August 26, 2022 Researchers say data shows transition from illicit to legal use of cannabis, with medicinal users up 34.5% since 2018. Prescient launches capital raise to progress pipeline of cancer therapies August 26, 2022 Special Report: Clinical stage oncology company Prescient Therapeutics to progress its deep pipeline of innovative cancer therapies with capital raise. Here’s what biotech Imugene needs to do before it can become a multibagger again August 25, 2022 The Imugene share price surged 20x to 71c before plunging to 25c in 2022 Here's what the experts predict will… ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results August 24, 2022 Healthcare giants Sonic and EBOS report solid full year results Trajan offers handy forward guidance Probiotic delivers record revenues The… Nutritional Growth Solutions on track for US presence in 420 physical retail stores in Q3 August 24, 2022 Special Report: Nutritional Growth Solutions is expanding its retail presence in the US with a distribution agreement with natural food… Osteopore is a step closer to the huge Chinese market after signing a distribution deal August 23, 2022 Special Report: Osteopore’s agreement with Kontour is the first step towards gaining entry into the Chinese market. ASX Health Stocks: Doctor Care Anywhere downgrades guidance, CEO steps down, shares tumble August 23, 2022 Lumos Diagnostics (ASX:LDX) has received US$270k in purchase orders for the manufacture of a unique, multi-assay, rapid diagnostic cartridge. Next» « Previous